The global Idiopathic Pulmonary Fibrosis (IDF) treatment market size was USD 3.51 Billion in 2022 and is expected to register a rapid revenue CAGR of 6.2% during the forecast period. Increasing Research & Development (R&D) activities and rapid technological advancements in pulmonary fibrosis are key factors driving market revenue growth. The report is formulated with the updated and...

The global live cell imaging market size was USD 2.09 Billion in 2022 and is expected to register a rapid revenue CAGR of 10.6% during the forecast period. Approval of high content screening techniques, increasing high-value investments for Research & Development (R&D), and prevalence of chronic diseases and rising demand for cell biology research and live cell imaging systems are key...

The global medical devices market size was USD 572.10 Billion in 2022 and is expected to register a revenue CAGR of 7.2% during the forecast period. Increasing investments in Research & Development (R&D) and technological advancements in medical devices and rising population and more awareness among the public are some of the key factors driving market revenue growth. The report is...

The global leukemia therapeutics market size was USD 7.81 Billion in 2022 and is expected to register a rapid revenue CAGR of 6.1% during the forecast period. Rapid growth of healthcare industries, rising prevalence of chronic diseases, and increasing Research & Development (R&D) activities and government investments and development of targeted medicines and immunotherapies are key...

The global healthcare predictive analytics arket size was USD 11.84 Billion in 2022 and is expected to register a rapid revenue CAGR of 24.7% during the forecast period. Rising demand for healthcare analytics, and rapid technological advancements in healthcare predictive analytics are key factors driving market revenue growth. The report is formulated with the updated and latest information of...

The global membrane chromatography market size was USD 320.0 Million in 2022 and is expected to register a rapid revenue CAGR of 17.6% during the forecast period. Rising regulatory compliance for purification process and safety and hygiene and increasing automation and user-friendly designs of membrane chromatography systems and use of membrane chromatography systems in the biopharmaceutical...

The global thoracolumbar spine devices market size was USD 5.60 Billion in 2022 and is expected to register a revenue CAGR of 4.7% during the forecast period. High prevalence of spinal disorders, and continuous technological advancements are key factors driving market revenue growth. The research report on the Thoracolumbar Spine Devices market is formulated through extensive primary...